Clinical trials recruiting for High-risk Prostate Cancer
15
Recruiting trials
11
US states with sites
5
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| New York | 3 |
| Illinois | 2 |
| South Carolina | 2 |
| Texas | 2 |
| Massachusetts | 1 |
| Missouri | 1 |
| New Jersey | 1 |
| Ohio | 1 |
| Oregon | 1 |
| Washington | 1 |
Top cities
Chicago, Illinois 2Houston, Texas 2New York, New York 2Basking Ridge, New Jersey 1Boston, Massachusetts 1Charleston, South Carolina 1Commack, New York 1Gahanna, Ohio 1Harrison, New York 1Los Angeles, California 1
Self-screener
Recruiting trials
- A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer
- A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- Androgen-responsive POSLUMA-guided Intra-prostatic Boost
- Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
- Delayed Pelvic Imaging With [68]Ga-PSMA PET/CT in a Patient With High-risk Prostate Cancer.
- FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
- Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
- Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
- PRospective Observational Study of STereotactic Body rAdiation Therapy With Androgen Deprivation Therapy for Organ-confined High-risk Prostate Cancer: the PROSTAR Trial
- Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
- Phase III Adaptive Adaptive Stereostactic Body Radiotherapy (SBRT) With Dose Escalation for High-Risk Prostate Cancer
- Radiation Therapy Approaches for People With Prostate Cancer
- Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
- Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET
- Tb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - TbeforePROST Trial.
Related conditions
Trials recruiting for High-risk Prostate Cancer often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234PSMA PET 4Prostate Cancers 11Prostate Cancer (Post Prostatectomy) 14Prostate Cancer Patients 5Prostate Cancer (Diagnosis) 26Prostate Cancer (Adenocarcinoma) 43Prostate CA 10Neoadjuvant Therapy 23Locally Advanced Prostate Cancer 6
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for High-risk Prostate Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.